Chi­nese cell ther­a­py com­pa­ny opens first US man­u­fac­tur­ing site

North Car­oli­na’s Re­search Tri­an­gle Park is get­ting an­oth­er res­i­dent.

A CARs­gen man­u­fac­tur­ing site — the com­pa­ny fo­cused on CAR T-cell ther­a­pies — has passed lo­cal in­spec­tion and will be­gin clin­i­cal man­u­fac­tur­ing soon.

The 35,520 square-foot site will add the man­u­fac­tur­ing ca­pac­i­ty for an­oth­er 700 pa­tients a year, the com­pa­ny said in a re­lease, and sup­port clin­i­cal stud­ies and com­mer­cial launch in North Amer­i­ca and Eu­rope.  Pre­vi­ous­ly, CARs­gens’ US clin­i­cal op­er­a­tions were based out of Hous­ton, Texas.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER